Our finding that PAD2 appears to function within the EGF signaling pathway to modulate DCIS tumor cell migration suggests that PAD2 and/or citrullination may have predictive power for identifying aggressive EGFR+ DCIS lesions. This evidence concerns the gene EGFR and neoplasm.